171 related articles for article (PubMed ID: 28065683)
1. Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis.
Campione E; Botta A; Di Prete M; Rastelli E; Gibellini M; Petrucci A; Bernardini S; Novelli G; Bianchi L; Orlandi A; Massa R; Terracciano C
Neuromuscul Disord; 2017 Feb; 27(2):163-169. PubMed ID: 28065683
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies.
Passeri E; Bugiardini E; Sansone VA; Valaperta R; Costa E; Ambrosi B; Meola G; Corbetta S
J Neurol Sci; 2013 Aug; 331(1-2):132-5. PubMed ID: 23809192
[TBL] [Abstract][Full Text] [Related]
4. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency in myotonic dystrophy type 1.
Terracciano C; Rastelli E; Morello M; Celi M; Bucci E; Antonini G; Porzio O; Tarantino U; Zenobi R; Massa R
J Neurol; 2013 Sep; 260(9):2330-4. PubMed ID: 23754696
[TBL] [Abstract][Full Text] [Related]
7. Spectral domain optical coherence tomography findings in myotonic dystrophy.
Abed E; D'Amico G; Rossi S; Perna A; Bianchi MLE; Silvestri G
Neuromuscul Disord; 2020 Feb; 30(2):144-150. PubMed ID: 32005494
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Neoplasms in Myotonic Dystrophy Type 1.
Marcoval J; Olivé M; Bonfill-Ortí M; Martínez-Molina L; Talavera-Belmonte A
Dermatology; 2016; 232(6):700-703. PubMed ID: 28249295
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of calcium metabolism in type 1 myotonic dystrophy.
Hlaing PM; Scott IA; Jackson RV
Intern Med J; 2019 Nov; 49(11):1412-1417. PubMed ID: 30963668
[TBL] [Abstract][Full Text] [Related]
11. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
12. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
14. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
[TBL] [Abstract][Full Text] [Related]
15. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
16. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
[TBL] [Abstract][Full Text] [Related]
17. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
18. Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study.
D'Ambrosio ES; Chuang K; David WS; Amato AA; Gonzalez-Perez P
Muscle Nerve; 2023 Aug; 68(2):142-148. PubMed ID: 36790141
[TBL] [Abstract][Full Text] [Related]
19. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
[TBL] [Abstract][Full Text] [Related]
20. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]